M. Choiniere et al., Efficacy and costs of patient-controlled analgesia versus regularly administered intramuscular opioid therapy, ANESTHESIOL, 89(6), 1998, pp. 1377-1388
Citations number
50
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Background: Many studies have shown the efficacy of patient-controlled anal
gesia (PCA). However, it is not clear whether PCA has clinical or economic
benefits in addition to efficient analgesia. The current study was designed
to evaluate these issues by comparing PCA with regularly administered intr
amuscular injections of opioids after hysterectomy.
Methods: This prospective study included 126 patients who underwent abdomin
al hysterectomy and were randomly assigned to receive PCA or regularly time
d intramuscular injections of morphine during a period of 48 h. Doses were
adjusted to provide satisfactory analgesia in both treatment groups. Pain a
t rest and With movement, functional recovery, drug side effects, and patie
nt satisfaction were measured using rating scales and questionnaires. The c
osts of PCA and intramuscular therapy were calculated based on personnel ti
me and drug and material requirements.
Results: Comparable analgesia Was observed with the two treatment methods,
with no significant differences in the incidence of side effects or patient
satisfaction. The medication dosage had to be adjusted significantly more
frequently in the intramuscular group than in the PCA patients. The PCA did
not favor a faster recuperation time compared with intramuscular therapy i
n terms of times to ambulation, resumption of liquid and solid diet, passag
e of bowel gas, or hospital discharge. The results of the economic evaluati
on, which used a cost-minimization model and sensitivity analyses, showed t
hat PCA was more costly than regular intramuscular injections despite the f
act that no costs for the pump were included in the analyses. Cost differen
ces Ln nursing time favoring PCA were offset by drug and material costs ass
ociated with this type of treatment.
Conclusions: Compared with regularly scheduled intramuscular dosing, PCA is
more costly and does not have clinical advantages for pain management afte
r hysterectomy. Because of the comparable outcomes, the general use of PCA
in similar patients should be questioned.